Charlotte's Web (CWBHF) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
26 Apr, 2026Mission and legacy
Founded as a mission-driven organization, not as a traditional company, and pioneered the CBD category.
Inspired by Charlotte Figi's story, which led to global awareness, legal changes, and research into hemp's health potential.
Recognized as the #1 CBD brand in the U.S. with over a decade of leadership in hemp-based wellness.
Brand strength and media presence
Featured across major media outlets, reaching tens of billions globally and building strong brand recognition.
Holds a world-class Net Promoter Score of 92.2%, reflecting high customer satisfaction and loyalty.
Product portfolio and innovation
Offers a broad range of products: tinctures, gummies, soft gels, topicals, pet chews, and mushroom blends targeting various wellness needs.
Launched Brightside line in 2025, featuring fast-acting, need-state-specific products like CBG gummies for focus and mushroom gummies for sleep.
Medical line addresses sleep, pain, anxiety, and overall wellness with advanced formulations and high-potency options.
Latest events from Charlotte's Web
- Shareholders to vote on BAT transaction, director elections, and key governance matters.CWBHF
Proxy filing16 Apr 2026 - Key votes include director elections and a debenture amendment that may shift company control.CWBHF
Proxy filing16 Apr 2026 - Shareholders to vote on BAT's conversion to a control person, reshaping ownership and governance.CWBHF
Proxy filing6 Apr 2026 - BAT's investment and debenture conversion will give it 40.8% ownership and expanded governance rights.CWBHF
Proxy filing1 Apr 2026 - Debt eliminated, revenue up, and new capital positions for Medicare-driven growth.CWBHF
Q4 202531 Mar 2026 - BAT transaction and regulatory momentum drive financial and strategic transformation.CWBHF
Proxy filing31 Mar 2026 - BAT's conversion and $10M investment will eliminate $65M debt and give it 40% ownership.CWBHF
Proxy filing31 Mar 2026 - Sequential revenue growth and cost cuts support breakeven and turnaround progress.CWBHF
Q2 20242 Feb 2026 - Cost discipline, new channels, and product innovation drive improved Q4 results.CWBHF
Q4 202424 Dec 2025